173 related articles for article (PubMed ID: 36649280)
21. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Liu X; Ding C; Tan W; Zhang A
Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
[TBL] [Abstract][Full Text] [Related]
22. A simplified approach using Taqman low-density array for medulloblastoma subgrouping.
Cruzeiro GAV; Salomão KB; de Biagi CAO; Baumgartner M; Sturm D; Lira RCP; de Almeida Magalhães T; Baroni Milan M; da Silva Silveira V; Saggioro FP; de Oliveira RS; Dos Santos Klinger PH; Seidinger AL; Yunes JA; de Paula Queiroz RG; Oba-Shinjo SM; Scrideli CA; Nagahashi SMK; Tone LG; Valera ET
Acta Neuropathol Commun; 2019 Mar; 7(1):33. PubMed ID: 30832734
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA profiling of pediatric Medulloblastoma.
Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
[TBL] [Abstract][Full Text] [Related]
24. Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma.
Fang H; Zhang Y; Lin C; Sun Z; Wen W; Sheng H; Lin J
Front Immunol; 2023; 14():1227143. PubMed ID: 37593739
[TBL] [Abstract][Full Text] [Related]
25. Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.
Huang PI; Lin SC; Lee YY; Ho DM; Guo WY; Chang KP; Chang FC; Liang ML; Chen HH; Liu YM; Yen SH; Wong TT; Chen YW
Childs Nerv Syst; 2017 Aug; 33(8):1285-1294. PubMed ID: 28488086
[TBL] [Abstract][Full Text] [Related]
26. Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.
Li Y; Jiang T; Shao L; Liu Y; Zheng C; Zhong Y; Zhang J; Chang Q
J Neurooncol; 2016 Sep; 129(3):423-431. PubMed ID: 27406588
[TBL] [Abstract][Full Text] [Related]
27. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
28. Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification.
Cho HW; Lee H; Ju HY; Yoo KH; Koo HH; Lim DH; Sung KW; Shin HJ; Suh YL; Lee JW
J Korean Med Sci; 2022 Feb; 37(7):e59. PubMed ID: 35191235
[TBL] [Abstract][Full Text] [Related]
29. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
[TBL] [Abstract][Full Text] [Related]
30. Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
Goschzik T; Zur Muehlen A; Doerner E; Waha A; Friedrich C; Hau P; Pietsch T
J Neuropathol Exp Neurol; 2021 Apr; 80(5):419-430. PubMed ID: 33870422
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort.
Wang Y; Huang J; Yin X; Xu Q; Sun Y; Yao Y; Xiong J
Acta Neurochir (Wien); 2024 Feb; 166(1):72. PubMed ID: 38329556
[TBL] [Abstract][Full Text] [Related]
32. Integration of immunohistochemistry, RNA sequencing, and multiplex ligation-dependent probe amplification for molecular classification of pediatric medulloblastoma.
Huang HY; Yu CH; Yang YL; Chang YH; Jou ST; Lin KH; Lu MY; Chang HH; Chou SW; Ni YL; Lin DT; Chen HY; Peng SS; Kuo MF; Yang SH
Pediatr Blood Cancer; 2022 Apr; 69(4):e29569. PubMed ID: 35119194
[TBL] [Abstract][Full Text] [Related]
33. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
[TBL] [Abstract][Full Text] [Related]
34. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
36. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
37. Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.
Aras Y; Dölen D; İribas Çelik A; Kılıç G; Kebudi R; Ünverengil G; Sabancı PA; İzgi AN
Childs Nerv Syst; 2021 Dec; 37(12):3733-3742. PubMed ID: 34550414
[TBL] [Abstract][Full Text] [Related]
38. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
[TBL] [Abstract][Full Text] [Related]
39. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
[TBL] [Abstract][Full Text] [Related]
40. Real-world data for pediatric medulloblastoma: can we improve outcomes?
Sedano P; Segundo CG; De Ingunza L; Cuesta-Álvaro P; Pérez-Somarriba M; Diaz-Gutiérrez F; Colino CG; Lassaletta A
Eur J Pediatr; 2021 Jan; 180(1):127-136. PubMed ID: 32564147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
